This note is from my newsfeed: I have no comments to make, but it seems important.
Zion Levi’s melanoma went into remission thanks to a powerful immunotherapy drug called nivolumab. Then he donated his faeces — and the microbes inside — to help others who had failed to respond to the treatment or whose cancers had become resistant to it.
It was a small trial — it involved only 26 people — but one in three of them benefited from the faecal microbial transfer (FMT).
Today, at least 30 FMT trials are under way around the world.
They hint at a new era of ‘ecological oncology’ and aim to uncover how the gut microbiome influences the progression of tumours, the effectiveness of treatments and the organisms that live in tumours themselves.